Tenax Therapeutics (TENX) Long-Term Investments (2015 - 2020)

Tenax Therapeutics (TENX) reported Long-Term Investments of $10723.0 for Q2 2020, down 96.38% sequentially from $296349.0 in Q3 2018.

Tenax Therapeutics (TENX) Long-Term Investments (2015 - 2020) Analysis & Trends

Tenax Therapeutics (TENX) has 5 years of Long-Term Investments data on file, last reported at $10723.0 in Q2 2020.

For the quarter ending Q2 2020, Long-Term Investments changed N/A year-over-year to $10723.0; the trailing twelve-month figure through Jun 2020 stood at $10723.0 (changed N/A YoY), and the FY2017 full-year result was $1.8 million, down 78.93% from the prior year.
Long-Term Investments slipped to $10723.0 in Q2 2020, from $296349.0 in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $19.6 million in Q2 2016 to a low of $10723.0 in Q2 2020.
A 4-year average of $5.5 million and a median of $2.3 million in 2017 frame the typical range for Long-Term Investments.
Across the five-year window, Long-Term Investments slumped 52.35% in 2016 and tumbled 91.07% in 2018, its largest moves.
Tracing TENX's Long-Term Investments over 4 years: stood at $8.6 million in 2016, then sank by 78.93% to $1.8 million in 2017, then tumbled by 83.62% to $296349.0 in 2018, then plunged by 96.38% to $10723.0 in 2020.
Business Quant data shows TENX's Long-Term Investments at $10723.0 in Q2 2020, $296349.0 in Q3 2018, and $297378.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	505,194.89
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	5.75 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	9.79 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Tenax Therapeutics	67,856.40	67,856.40	-	-

Download Data